Rockwell heralds PhIII success for iron-delivery drug; Combined drugs could help treat HIV;

> Rockwell Medical ($RMTI) welcomed positive results in a Phase III study for its iron-delivery drug, showing the treatment increased hemoglobin in patients receiving hemodialysis. More

> Researchers at the University of Minnesota have developed a delivery system that combines two FDA-approved drugs that, together, could be an effective treatment for HIV. Story

> MusclePharm Corporation invested $2 million in BioZone, which has a drug delivery platform, QuSome, that enhances the absorption of topical and other drugs. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.